Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic ...

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, ...

Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding.

Needham analysts report that ICU Medical has a plan in place to handle its exposure to the tariffs imposed by the Trump ...

Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer ...

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication adherence.

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion ...